Search
for
Sort by
Research 331–360 of 1000+
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Non-scarring alopecia in systemic lupus erythematosus patients at the Lagos State University Teaching Hospital: a cross-sectional study of prevalence, pattern, trichoscopy features and histopathological analysis
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Comparative histopathological analyses of non-scarring alopecia in systemic lupus erythematosus patients in Lagos Nigeria
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Self-Assessment
- 270 A novel small compound HPH-15 antagonizes TGF-β/Smad signaling and ameliorates experimental skin fibrosis
- Fever of unknown origin in a male patient with systemic lupus erythematosus.
- Cutaneous Manifestations of Lupus Erythematosus
- Book Reviews
- ANNOUNCEMENTS
- HAIR REGROWTH
- Toxic Epidermal Necrolysis
- Primary cicatricial alopecia
- A Practical Guide to Scalp Disorders
- Age-related hair changes in men: Mechanisms and management of alopecia and graying
- Molecular characterization of xerosis cutis: A systematic review
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome
- Alopecia and Hirsuties
- Medical dermatologic conditions in transgender women
- Update on the Treatment of Alopecia Areata
- Dermatosis associated with menopause
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Skin health and integrity
- Modulation of Hair Growth Promoting Effect by Natural Products
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib